drugset / Trial / NCT00180635

NO Donors and Inhibitors to Study Imbalance of Nitrogen Stress and Antioxidant Defense in COPD

NCT00180635 ↗

Completed 30 enrolled Imperial College London
RandomizedCrossoverDouble-blindTreatment

Summary

The primary aim of this study is to investigate the effects of oral and inhaled administration of L-arginine and of inhaled aminoguanidine on bronchial and alveolar exhaled NO and NO metabolites in exhaled breath condensate, induced sputum, nasal lavage and mouth wash fluid in healthy non-smokers, current smokers and patients with COPD.

Timeline

Start
2003-10
Primary completion
2006-07
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject PIMAGEDINE Small molecule 500 mg Inhaled